Cargando…
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
BACKGROUND: Allogeneic hematopoietic stem cell transplantation is a well-established approach for patients diagnosed with primary myelofibrosis and remains the only potentially curative treatment. AIMS: To present the overall outcome of patients with myelofibrosis treated with allogeneic hematopoiet...
Autores principales: | Cengiz Seval, Guldane, Civriz Bozdag, Sinem, Kocak Toprak, Selami, Kurt Yuksel, Meltem, Topcuoglu, Pervin, Arslan, Onder, Demirer, Taner, Gurman, Gunhan, Beksac, Meral, Ilhan, Osman, Ozcan, Muhit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175888/ https://www.ncbi.nlm.nih.gov/pubmed/36959692 http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2022-2-32 |
Ejemplares similares
-
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
por: Kırcalı, Ekin, et al.
Publicado: (2023) -
PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
por: Yilmaz, Hulya, et al.
Publicado: (2023) -
Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
por: Narlı Özdemir, Zehra, et al.
Publicado: (2021) -
Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
por: Kırcalı, Ekin, et al.
Publicado: (2022) -
A Randomized Comparison of Hemoglobin Content-Based Versus Standard (Unit-Based) Red Blood Cell Transfusion Policy
por: Atilla, Erden, et al.
Publicado: (2017)